Ion pumps as targets for therapeutic intervention: Old and new paradigms

The development of an effective target for therapeutic intervention remains a critical part of the drug discovery process. One such target class is the P-type ion translocating ATPases, which include the Na+,K+-ATPase of cardiac cells and the H+,K+-ATPase of gastric parietal cells. These enzymes ser...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Perlin,David S.
Lenguaje:English
Publicado: Pontificia Universidad Católica de Valparaíso 1998
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-34581998000200002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0717-34581998000200002
record_format dspace
spelling oai:scielo:S0717-345819980002000022003-08-18Ion pumps as targets for therapeutic intervention: Old and new paradigmsPerlin,David S. The development of an effective target for therapeutic intervention remains a critical part of the drug discovery process. One such target class is the P-type ion translocating ATPases, which include the Na+,K+-ATPase of cardiac cells and the H+,K+-ATPase of gastric parietal cells. These enzymes serve as selective targets for digoxin and omeprazole, which are used to treat heart disease and gastrointestinal ulcers, and are two of the leading prescribed therapeutics worldwide. It is the exquisite selectivity that can be achieved between family members that continues to make the P-type enzymes desirable targets for developing new therapeutics including a new generation of antiulcer therapeutic and a new class of antifungal therapeutic.info:eu-repo/semantics/openAccessPontificia Universidad Católica de ValparaísoElectronic Journal of Biotechnology v.1 n.2 19981998-08-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-34581998000200002en10.4067/S0717-34581998000200002
institution Scielo Chile
collection Scielo Chile
language English
description The development of an effective target for therapeutic intervention remains a critical part of the drug discovery process. One such target class is the P-type ion translocating ATPases, which include the Na+,K+-ATPase of cardiac cells and the H+,K+-ATPase of gastric parietal cells. These enzymes serve as selective targets for digoxin and omeprazole, which are used to treat heart disease and gastrointestinal ulcers, and are two of the leading prescribed therapeutics worldwide. It is the exquisite selectivity that can be achieved between family members that continues to make the P-type enzymes desirable targets for developing new therapeutics including a new generation of antiulcer therapeutic and a new class of antifungal therapeutic.
author Perlin,David S.
spellingShingle Perlin,David S.
Ion pumps as targets for therapeutic intervention: Old and new paradigms
author_facet Perlin,David S.
author_sort Perlin,David S.
title Ion pumps as targets for therapeutic intervention: Old and new paradigms
title_short Ion pumps as targets for therapeutic intervention: Old and new paradigms
title_full Ion pumps as targets for therapeutic intervention: Old and new paradigms
title_fullStr Ion pumps as targets for therapeutic intervention: Old and new paradigms
title_full_unstemmed Ion pumps as targets for therapeutic intervention: Old and new paradigms
title_sort ion pumps as targets for therapeutic intervention: old and new paradigms
publisher Pontificia Universidad Católica de Valparaíso
publishDate 1998
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-34581998000200002
work_keys_str_mv AT perlindavids ionpumpsastargetsfortherapeuticinterventionoldandnewparadigms
_version_ 1718441679213559808